Electra Therapeutics, Inc. (ETRA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-16
2:00 pm
Purchase
2026-09-3013GELECTRA THERAPEUTICS INC
ETRA
Cormorant Asset Management LP3,365,533
5.360%
3,365,533increase
(New Position)
Filing
History
2026-10-29
5:59 pm
Purchase
2026-09-3013GELECTRA THERAPEUTICS INC
ETRA
Westlake BioPartners Fund I, L.P.6,347,539
10.100%
6,347,539increase
(New Position)
Filing
History
2026-09-28
9:00 pm
Purchase
2026-09-2113GELECTRA THERAPEUTICS INC
ETRA
Redmile Group LLC5,462,881
8.700%
5,462,881increase
(New Position)
Filing
History
2026-09-28
9:00 pm
Purchase
2026-09-2113GELECTRA THERAPEUTICS INC
ETRA
LSP 7 Cooperatief U.A.3,795,281
6.000%
3,795,281increase
(New Position)
Filing
History
2026-09-25
5:11 pm
Purchase
2026-09-2113DELECTRA THERAPEUTICS INC
ETRA
OrbiMed Advisors LLC6,885,170
11.000%
6,885,170increase
(New Position)
Filing
History